Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.63 on revenue of $1.37B. Analysts polled by Investing.com anticipated EPS of $0.6407 on revenue of $1.4B. .
Edwards Lifesciences shares lost 5.86% to trade at $101.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 19.5%, under-performing the S&P 500 which is down 14.56% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On July 15, UnitedHealth reported second quarter EPS of $5.57 on revenue of $80.33B, compared to forecasts of EPS of $5.21 on revenue of $79.68B.
J&J earnings beat analyst's expectations on July 19, with second quarter EPS of $2.59 on revenue of $24.02B. Investing.com analysts expected EPS of $2.54 on revenue of $23.77B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar